A9610 HCPCS Level II code: Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
A9610 is the HCPCS code for “Xenon xe-129 hyperpolarized gas, diagnostic, per study dose” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
A9610Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
Short description: Xe129 xenon, diagnostic
HCPCS · United States
Medicare details
The indicators CMS publishes with A9610 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Other carrier priced
- Type of service
- Diagnostic radiology
- BETOS category
- Standard imaging - nuclear medicine
- Added
- Oct 1, 2024
Where A9610 sits
- 1A codesAmbulance, supplies and miscellaneous
- 2Active code A9610Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code A9610 mean?
A9610 is the HCPCS code for “Xenon xe-129 hyperpolarized gas, diagnostic, per study dose” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover A9610?
CMS lists A9610’s Medicare coverage as “Carrier judgment” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside A9610
All A codesA9603Injection, pafolacianine, 0.1 mgA9604Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuriesA9606Radium ra-223 dichloride, therapeutic, per microcurieA9607Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurieA9608Flotufolastat f 18, diagnostic, 1 millicurieA9609Fludeoxyglucose f18 up to 15 millicuriesA9611Flurpiridaz f 18, diagnostic, 1 millicurieA9612Injection, fluorescein, 1 mgA9613Piflufolastat f 18 (pylarify truvu), diagnostic, 1 millicurieA9615Injection, pegulicianine, 1 mgA9616Gallium ga-68 gozetotide (gozellix), diagnostic, 1 millicurieA9697Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose